Skip to content

The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical Prostatectomy

The Ability of Adipose Flap Over the NVB to Improve Sexual and Urinary Function Following Radical Prostatectomy; a Randomized Control Trial

Status
UNKNOWN
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04577222
Enrollment
60
Registered
2020-10-06
Start date
2018-04-15
Completion date
2022-07-15
Last updated
2020-10-06

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Erectile Dysfunction, Prostate Cancer, Urinary Incontinence

Brief summary

Despite technological advances, incontinence and impotence remain significant side effects of radical prostatectomy (RP). Strategies have been developed to reduce the injury to the erection nerves (i.e. neurovascular bundle - NVB)during surgery to further improve functional outcomes after RP. Adipose tissue is known for its stabilizing and even healing potential. These features include reducing the inflammatory process and improving blood supply to an injured nerve. We hypothesized that covering the NVB with periprostatic fat during surgery may potentially improve neural recovery and enhance functional recovery after RP. We sought to examine our hypothesis in a randomized controlled trial.

Interventions

PROCEDURETechnical modification during radical prostatectomy

Covering the NVB with fat

Sponsors

Rabin Medical Center
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
OTHER
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
MALE
Healthy volunteers
No

Inclusion criteria

1. Male aged 18 years and older. 2. Patients diagnosed with prostate cancer. 3. Patients should be potent (IIEF erectile function domain score of 26 and above) and have a sexual partner. 4. Patients scheduled for Radical Prostatectomy with NVB preservation (at least unilateral).

Exclusion criteria

Patients who did not undergo NVB preservation or technical inability to create flap

Design outcomes

Primary

MeasureTime frameDescription
Erectile functionChange from Baseline IIEF score at 12 monthsIIEF erectile function score

Secondary

MeasureTime frameDescription
Continence statusChange from Baseline King's score at 12 monthsKing's Health Questionnaire score

Countries

Israel

Contacts

Primary ContactShay Golan, MD
Shaygo1@gmail.com+972507447573

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026